Skip to main content

Adhera Therapeutics, Inc. (ATRX)

OTCMKTS: ATRX · Delayed Price · USD
0.1140 -0.0060 (-5.00%)
Sep 10, 2021 10:19 AM EDT - Market closed

Company Description

Adhera Therapeutics, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States.

The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Adhera Therapeutics, Inc.
CountryUnited States
IndustryBiotechnology
SectorHealth Care

Contact Details

Address:
17870 Castleton St Ste 250
City Of Industry, California 91748-6732
United States
Phone919 518 3748

Stock Details

Ticker SymbolATRX
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0000737207
CUSIP Number00687E109
ISIN NumberUS00687E1091
Employer ID11-2658569

Key Executives

NamePosition
Andrew Albert KucharchukChief Executive Officer and Chairman
Dr. Peter D. Weinstein Ph.D., J.D.Chief Legal Officer
Dr. Seymore Howard FeinChief Medical Officer
Jay D. SchwartzSenior Vice President of Commercial Operations